Are Aminoglycoside Antibiotics TRPing Your Metabolic Switches?

Alfredo Franco-Obregón1,2,3,4,5,6, Yee Kit Tai1,2,3,4

  • 1Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.

Cells
|August 9, 2024
PubMed

Insights

Aminoglycoside antibiotics disrupt calcium signaling in Transient Receptor Potential (TRP) channels, affecting muscle and adipose tissue development. Researchers must consider this when using these antibiotics in studies.

Area of Science:

  • Cellular Biology
  • Metabolic Research
  • Pharmacology

Background:

  • Transient Receptor Potential (TRP) channels regulate calcium influx crucial for skeletal muscle and adipose tissue development and systemic metabolic balance.
  • Aminoglycoside antibiotics (AGAs) are known to block calcium conduction through TRP channels in response to various stimuli.
  • The common use of streptomycin, an AGA, for bacterial contamination in cell cultures may confound research findings.

Purpose of the Study:

  • To investigate the impact of aminoglycoside antibiotics (AGAs) on TRP channel function and its consequences for muscle and adipose tissue development.
  • To highlight the paradoxical effects of streptomycin, an AGA, on myogenesis and adipose tissue thermogenesis.
  • To alert the scientific community about the potential for AGAs to disrupt TRP-mediated calcium signaling and systemic metabolism.

Main Methods:

  • Review of existing literature on TRP channel function, AGA mechanisms, and their effects on cellular development.
  • Analysis of studies investigating streptomycin's impact on myogenesis, adipogenesis, and in vivo metabolic adaptations.
  • Examination of streptomycin's role in managing calcium leakage in dystrophic muscle models.

Main Results:

  • AGAs, specifically streptomycin, disrupt TRP channel-mediated calcium entry, interfering with myogenesis and the white-to-beige adipose tissue switch.
  • In vivo, streptomycin impairs TRP-dependent, calcium-mediated exercise adaptations vital for metabolism.
  • Streptomycin has been used to mitigate detrimental calcium leakage in dystrophic skeletal muscle via TRPC1 channels.

Conclusions:

  • TRP channels antagonized by AGAs are critical for muscle and adipose tissue development and systemic metabolism.
  • The administration of AGAs in experimental models can lead to widespread metabolic disruption.
  • The regenerative medicine and clinical communities should be aware of this significant caveat and seek alternative methods for contamination prevention.

Related Concept Videos

Factors Affecting Drug Biotransformation: Biological01:19

Factors Affecting Drug Biotransformation: Biological

Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
135
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs01:21

Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in...
218
Regulation of Metabolism01:19

Regulation of Metabolism

Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
9.3K
Riboswitches01:56

Riboswitches

Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
8.1K
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.3K
Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K